NCT00443118

Brief Summary

A multicenter cross-over cluster randomized controlled trial protocol study in newborn infants ≥ 26 weeks gestational age requiring assisted ventilation (positive pressure ventilation \[PPV\]) for resuscitation in the delivery room comparing a T-piece resuscitator device versus resuscitation bag.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,032

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Dec 2009

Typical duration for phase_3

Geographic Reach
5 countries

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 5, 2007

Completed
2.7 years until next milestone

Study Start

First participant enrolled

December 1, 2009

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

March 31, 2015

Completed
Last Updated

September 28, 2018

Status Verified

August 1, 2018

Enrollment Period

2.7 years

First QC Date

March 2, 2007

Results QC Date

February 22, 2014

Last Update Submit

August 31, 2018

Conditions

Keywords

Bag and maskNeopuffResuscitationNewbornIntubationdevicesPEEP

Outcome Measures

Primary Outcomes (1)

  • Proportion of Infants With a HR ≥ 100 Bpm at 2 Minutes of Life.

    2 minutes of life

Secondary Outcomes (13)

  • Time the Newborn Takes to Reach a HR > 100 Bpm

    2 minutes of life

  • • SpO2 Value at 2 Minutes of Life.

    2 minutes of life

  • • Proportion of Eligible Newborns Who Entered the Study and Who Were Intubated After Failure of PPV With Mask.

    after 2 minutes of life

  • • Need for Chest Compression and/or Medications

    after 2 minutes of life

  • Apgar Scores at 1 and 5 Minutes

    1-5 minutes of life

  • +8 more secondary outcomes

Study Arms (3)

Neopuff TM with PEEP

ACTIVE COMPARATOR

Newborns ventilated for neonatal resuscitation using Neopuff TM with PEEP

Device: T-piece resuscitator Neopuff TM

Self Inflating Bag with PEEP

ACTIVE COMPARATOR

Newborns ventilated for neonatal resuscitation using Self Inflating Bag with PEEP valve attached

Device: Self Inflating Bag with PEEP

Self Inflating Bag without PEEP

ACTIVE COMPARATOR

Newborns ventilated for neonatal resuscitationusing Self Inflating Bag without PEEP valve attached

Device: Self Inflating Bag without PEEP

Interventions

Positive pressure ventilation will be performed with Neopuff® with face mask. For this study, an initial PIP 25 cm H2O and a 5 cm H2O PEEP will be used for resuscitation according to protocol.

Neopuff TM with PEEP

Positive pressure ventilation will be performed with Self Inflating Bag with PEEP with face mask. For this study, an initial PIP 25 cm H2O and a 5 cm H2O PEEP will be used for resuscitation according to protocol.

Also known as: Ambu
Self Inflating Bag with PEEP

Positive pressure ventilation will be performed with Self Inflating Bag without PEEP with face mask. For this study, an initial PIP 25 cm H2O and a 5 cm H2O PEEP will be used for resuscitation according to protocol.

Also known as: Ambu
Self Inflating Bag without PEEP

Eligibility Criteria

AgeUp to 2 Minutes
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Live-born infants of ≥ 26 weeks' GA with HR \< 100 bpm requiring resuscitation with positive pressure ventilation with mask in the delivery room according to the current AAP/AHA recommendations

You may not qualify if:

  • Infants requiring intubation from birth. Newborns of \< 26 weeks´ GA. Newborns presenting major congenital malformations. Multiple births. Problems (difficulty or malfunctioning) with the device assigned.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Carol Jo Vecchie Women and Children's Center at St. John's Hospital

Springfield, Illinois, 19676, United States

Location

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Sanatorio de los Arcos

Ciudad de Buenos Aires, Buenos Aires, C1425FSD, Argentina

Location

Hospital Universitario Austral

Pilar, Buenos Aires, Argentina

Location

Hospital Misericordia

Córdoba, Argentina

Location

Nuevo Hospital El Milagro de Salta

Salta, 4400, Argentina

Location

Hospital Clínico de la Pontificia Universidad Católica de Chile

Santiago, 8330024, Chile

Location

Hospital Dr. Hernán Henriquez Aravena

Temuco, Chile

Location

Hospital Dr. Gustavo Fricke

Viña del Mar, Chile

Location

Azienda Ospedaliera Padova

Padua, Veneto, 35128, Italy

Location

Instituto Nacional Materno Perinatal (INMP) de Perú

Lima, Peru

Location

Related Publications (1)

  • Szyld E, Aguilar A, Musante GA, Vain N, Prudent L, Fabres J, Carlo WA; Delivery Room Ventilation Devices Trial Group. Comparison of devices for newborn ventilation in the delivery room. J Pediatr. 2014 Aug;165(2):234-239.e3. doi: 10.1016/j.jpeds.2014.02.035. Epub 2014 Mar 29.

Related Links

MeSH Terms

Interventions

Positive-Pressure Respiration

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Results Point of Contact

Title
Edgardo Szyld MD, MSc
Organization
FUNDASAMIN-Fundacion para la Salud Materno Infantil

Study Officials

  • Edgardo Szyld, MD

    Fundasamin

    PRINCIPAL INVESTIGATOR
  • Adriana Aguilar, MD

    Hospital Paroissien

    STUDY DIRECTOR
  • Waldemar Carlo, MD

    University of Alabama at Birmingham

    STUDY CHAIR
  • Nestor Vain, MD

    Sanatorio de la Trinidad

    STUDY DIRECTOR
  • Luis Prudent, MD

    Sanatorio Otamendi

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 2, 2007

First Posted

March 5, 2007

Study Start

December 1, 2009

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

September 28, 2018

Results First Posted

March 31, 2015

Record last verified: 2018-08

Locations